Elf-1 contributes to the function of the complex interleukin (IL)-2-responsive enhancer in the mouse IL-2 receptor alpha gene.
Data(s) |
1997
|
---|---|
Resumo |
Lymphocytes regulate their responsiveness to IL-2 through the transcriptional control of the IL-2R alpha gene, which encodes a component of the high affinity IL-2 receptor. In the mouse IL-2R alpha gene this control is exerted via two regulatable elements, a promoter proximal region, and an IL-2-responsive enhancer (IL-2rE) 1.3 kb upstream. In vitro and in vivo functional analysis of the IL-2rE in the rodent thymic lymphoma-derived, CD4- CD8- cell line PC60 demonstrated that three separate elements, sites I, II, and III, were necessary for IL-2 responsiveness; these three sites demonstrate functional cooperation. Site III contains a consensus binding motif for members of the Ets family of transcription factors. Here we demonstrate that Elf-1, an Ets-like protein, binds to site III and participates in IL-2 responsiveness. In vitro site III forms a complex with a protein constitutively present in nuclear extracts from PC60 cells as well as from normal CD4- CD8- thymocytes. We have identified this molecule as Elf-1 according to a number of criteria. The complex possesses an identical electrophoretic mobility to that formed by recombinant Elf-1 protein and is super-shifted by anti-Elf-1 antibodies. Biotinylated IL-2rE probes precipitate Elf-1 from PC60 extracts provided site III is intact and both recombinant and PC60-derived proteins bind with the same relative affinities to different mutants of site III. In addition, by introducing mutations into the core of the site III Ets-like motif and comparing the corresponding effects on the in vitro binding of Elf-1 and the in vivo IL-2rE activity, we provide strong evidence that Elf-1 is directly involved in IL-2 responsiveness. The nature of the functional cooperativity observed between Elf-1 and the factors binding sites I and II remains unresolved; experiments presented here however suggest that this effect may not require direct interactions between the proteins binding these three elements. |
Identificador |
https://serval.unil.ch/?id=serval:BIB_1366 isbn:0022-1007 (Print) pmid:9104808 doi:10.1084/jem.185.7.1211 isiid:A1997WU18300007 http://my.unil.ch/serval/document/BIB_1366.pdf http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_13662 |
Idioma(s) |
en |
Direitos |
info:eu-repo/semantics/openAccess |
Fonte |
Journal of Experimental Medicine, vol. 185, no. 7, pp. 1211-1221 |
Palavras-Chave | #Animals; Base Sequence; Binding Sites; DNA-Binding Proteins/genetics; DNA-Binding Proteins/metabolism; Enhancer Elements, Genetic; Ephrin-A2; Interleukin-2/pharmacology; Mice; Molecular Sequence Data; Mutation; Nuclear Proteins/metabolism; Protein Binding; Proto-Oncogene Proteins/genetics; Proto-Oncogene Proteins c-ets; Receptors, Interleukin-2/genetics; T-Lymphocytes/metabolism; Transcription Factors/genetics; Transcription Factors/metabolism; Tumor Cells, Cultured |
Tipo |
info:eu-repo/semantics/article article |